ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 1 filers reported holding ZEALAND PHARMA A S in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $312,000 | -15.4% | 23,976 | +1.1% | 0.00% | – |
Q1 2022 | $369,000 | -29.3% | 23,714 | -3.0% | 0.00% | – |
Q4 2021 | $522,000 | +76.9% | 24,441 | +143.6% | 0.00% | – |
Q3 2021 | $295,000 | -68.8% | 10,032 | -68.9% | 0.00% | – |
Q2 2021 | $946,000 | -27.1% | 32,210 | -20.6% | 0.00% | -100.0% |
Q1 2021 | $1,297,000 | +1.1% | 40,590 | +13.7% | 0.00% | 0.0% |
Q4 2020 | $1,283,000 | +26.8% | 35,707 | +35.5% | 0.00% | 0.0% |
Q3 2020 | $1,012,000 | -20.4% | 26,355 | -27.5% | 0.00% | 0.0% |
Q2 2020 | $1,272,000 | +121.2% | 36,331 | +118.1% | 0.00% | 0.0% |
Q1 2020 | $575,000 | +19.3% | 16,656 | +22.2% | 0.00% | 0.0% |
Q4 2019 | $482,000 | +58.6% | 13,634 | +14.2% | 0.00% | 0.0% |
Q3 2019 | $304,000 | -5.0% | 11,942 | -52.8% | 0.00% | 0.0% |
Q4 2018 | $320,000 | +92.8% | 25,285 | +134.2% | 0.00% | – |
Q1 2018 | $166,000 | -34.6% | 10,798 | -41.8% | 0.00% | -100.0% |
Q4 2017 | $254,000 | -34.2% | 18,558 | -7.2% | 0.00% | 0.0% |
Q3 2017 | $386,000 | – | 19,999 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 320,719 | $4,817,000 | 0.93% |
FARALLON CAPITAL MANAGEMENT LLC | 865,000 | $12,992,000 | 0.09% |
WELLINGTON MANAGEMENT GROUP LLP | 1,938,996 | $29,123,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 170,844 | $2,566,000 | 0.00% |
Laurion Capital Management LP | 16,617 | $250,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,291 | $19,000 | 0.00% |
UNITED SERVICES AUTOMOBILE ASSOCIATION | 24,500 | $368,000 | 0.00% |
ROYCE & ASSOCIATES LP | 10,000 | $150,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 875 | $14,000 | 0.00% |
MORGAN STANLEY | 2,297 | $35,000 | 0.00% |